Working in collaboration with partners, GALVmed has implemented, over the years, impactful programmes across Africa and South Asia. These are some of GALVmed’s achievements from 2014 to 2022.

With a rapidly growing population and demand for animal-derived protein, enabling the veterinary sector to address the diverse needs and challenges of small-scale producers is not only possible, but also critical to Africa’s sustainable development.

The misuse of antibiotics in both human and animal health has created an urgent health emergency globally. The resistance of microbes to antibiotics that are constantly used to combat them makes infections harder to treat, creating an antimicrobial resistance (AMR) crisis directly responsible for up to 1.27 million global human deaths as of 2019.

Understanding how adoption translates into economic and other benefits for SSPs is central to our mission. Monitoring and Evaluation (M&E) gives us a structured way to assess these outcomes.

At GALVmed, Monitoring and Evaluation (M&E) is not an afterthought. It is integrated from the very start of the development of new projects and programmes. This approach ensures that our projects are designed with a clear vision of impact.

As of June 2024, the Mutual Recognition Procedure has been extended to also include registration of veterinary ectoparasiticides.

A functioning regulatory framework helps to equip livestock producers with quality products, supporting them to protect their livelihoods and their vital contributions to continental food security.

The Better Regulation project is set to further improve the regulatory systems in sub-Saharan Africa required to bring new veterinary products into market.

Three years since inception and with over a year left on the project, PREVENT has performed remarkably and is on track to achieving, and in some instances exceeding, its targets.

For the past few years, GALVmed has been working with a wide range of partners to create a suite of digital platforms designed to finally bridge the gaps between the animal health industry and the continent’s small-scale producers.

In 2020, LAPROVET, a Ceva Santé Animale group company, partnered with GALVmed and launched the OneLab initiative, a programme to develop a network of private veterinary laboratories in Senegal to facilitate access to diagnostic tools.